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ABSTRACT 
Background: The financial impact of cancer on survivors’ lives, and its consequences, remain poorly 
understood. This is especially true for colorectal cancer.   
Objective: We investigated objective cancer-related financial stress, subjective cancer-related 
financial strain and their association with health-related quality-of-life in colorectal cancer survivors. 
Design: Cross-sectional postal survey 
Setting: Ireland, which has a mixed public-private healthcare system 
Patients: Colorectal cancer survivors, diagnosed 6-37 months previously, were identified from the 
population-based National Cancer Registry. 
Main Outcome Measures: Cancer-related financial stress was assessed as impact of cancer on 
household ability to make ends meet; and cancer-related financial strain by feelings about 
household financial situation since cancer diagnosis. Health-related quality-of-life was based on 
European Organisation for Research and Treatment of Cancer QLQ-C30 global health status. Logistic 
regression was used to identify associations between financial stress and strain and low health-
related quality-of-life (lowest quartile, score ≤50). 
Results: 493 survivors participated. Overall, 41% reported cancer-related financial stress and 39% 
cancer-related financial strain; 32% reported both financial stress and financial strain.  After 
adjustment for socio-demographic and clinical variables, the odds of low health-related quality-of-
life were significantly higher in those who reported cancer-related financial stress post-diagnosis 
compared to those who reported no change in financial stress post-cancer (odds ratio=2.54, 95% 
confidence interval 1.62-3.99).  The odds of low health-related quality-of-life were also significantly 
higher in those with worse financial strain post-diagnosis (1.73, 1.09-2.72). The odds ratio for those 
with both cancer-related financial stress and financial strain was 2.59 (1.59-4.22). 
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Limitations: Survey responders were younger, on average, than non-responders. Responders and 
non-responders may have differed in cancer-related financial stress and strain or health-related 
quality-of-life. 
Conclusions: Four in ten colorectal cancer survivors reported an adverse financial impact of cancer. 
Cancer-related financial stress and strain were significantly associated with low health-related 
quality-of-life.  To inform support strategies, further research is needed to better understand how 
both objective and subjective financial distress influence survivors’ health-related quality-of-life. 
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INTRODUCTION 
Population ageing and rising survival mean that more people are living with colorectal cancer. In 
developed countries, substantial health service-related costs are associated with diagnosis, 
treatment and follow-up of colorectal cancer.1,2  Increasingly, however, there is recognition that 
additional perspectives on the economic burden of merit consideration, including that of those living 
with the cancer.   
 
Colorectal cancer patients may incur cancer-related out-of-pocket expenses (e.g. for medical visits or 
treatment)3-6 and/or loss of income due to cancer-related work absence,7,8 and these have the 
potential to lead to cancer-related financial hardship. Although the literature on financial hardship 
among cancer survivors is growing,9-14 it has significant limitations. Few studies are specific to 
colorectal cancer, most come from a few mainly public or mainly private healthcare systems, and 
very few specify whether the hardship is a result of the cancer diagnosis or simply reflects pre-
existing financial difficulties. One study which did focus on the financial impact of the cancer found 
that 38% of colon cancer patients in the US experienced one or more financial hardships resulting 
from treatment.15 
 
A further limitation relates to measurement of cancer-related financial hardship. In assessing the 
financial impact of illness, both objective and subjective measures of impact should be 
considered.16,17 An objective measure assesses the impact of financial stressors experienced by the 
household, such as additional costs, while a subjective measure characterises how an individual 
perceives the financial impact. No colorectal cancer studies (and very few studies of other cancers) 
have considered these two dimensions of cancer-related financial impact. 
 
Moreover, the wider consequences of cancer-related financial difficulties on colorectal cancer 
survivors’ lives are underreported. Studies in other cancers have indicated that patients who 
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experience financial hardship, difficulties or distress may have poorer psychological wellbeing, 
general wellbeing or health-related quality-of-life (HRQoL)18-21 but there has been little similar work 
in colorectal cancer.14,22,23  
 
This study aimed to investigate – for the first time - associations between objective cancer-related 
financial stress and subjective cancer-related financial strain and HRQoL in colorectal cancer 
survivors, in a country with a mixed public-private healthcare system.  
METHODS 
Setting 
The study setting was Ireland, which has a complex mixed public-private healthcare system.24  All 
residents are entitled to care within the public system. Cancer care within the public system has 
been largely centralised. For colorectal cancer treatment, there are eight designated cancer centres 
and 85-90% of those who undergo surgery are treated in public hospitals. Unless an individual holds 
a medical card (eligibility for which is based on financial means and age), they must make modest co-
payments for visits to doctors or overnight stays in public hospitals (e.g. approximately €60 to visit a 
GP) and pay full cost of prescription medications.  Approximately half of the population holds private 
health insurance which, in the main, covers hospital in-patient stays either in a private hospital or as 
a private patient in a within a public hospital; costs of GP visits, and prescriptions medications, are 
not usually covered. Individuals may join the Drug Payment Scheme which applies a ceiling - €120 
per month - to the amount that they have to pay for prescription drugs and certain aids (including 
ostomy appliances). 
 
Participants 
In January 2010, survivors of primary, invasive colorectal cancer (ICD10 C18-C20) were identified 
through the National Cancer Registry (NCR). Cancer registration is population-based and 
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completeness is estimated to be in excess of 97%. Survivors had to be diagnosed between October 
2007 and September 2009, believed to be still alive and treated at one of 38 hospitals. Treating 
clinicians were asked to confirm whether each individual was (i) aware they had cancer; (ii) able to 
understand English; and (iii) well enough to participate (in particular, cognitively able to give 
informed consent).   Those who were not eligible on this basis, or whose clinician did not respond, 
were excluded.  A questionnaire was sent by post to 1,273 eligible individuals; survivors were 
between 6 and 37 months from diagnosis at the time they received the questionnaire. Non-
responders were sent up to two reminders at fortnightly intervals.  
 
The study was approved by the research ethics committees of the hospitals at which the survivors 
had been treated. Participants provided written informed consent. 
 
Questionnaire and other data 
Health-related quality-of-life  
The questionnaire included the European Organisation for Research and Treatment of Cancer 
(EORTC) QLQ-C30, which has been developed and validated to assess different aspects of HRQoL in 
patients with a range of cancers from different countries.25,26  The final two questions, which ask 
respondents to rate their health and quality-of-life over the past week on a scale of 1 (very poor) to 
7 (excellent), constitute the global health score which can be interpreted as a measure of overall 
HRQoL. The questions were scored as recommended to generate a single value in the range from 0 
(poorest HRQoL) to 100 (best HRQoL).    
 
Cancer-related financial stress and strain 
Following Francoeur16 and previous work on financial hardship among cancer survivors in Ireland,20,27 
the questionnaire included one objective and one subjective measure of cancer-related financial 
impact – the former termed cancer-related financial stress and the latter cancer-related financial 
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strain. Cancer-related financial stress was assessed as the impact of the cancer diagnosis on the 
household’s ability to make ends meet, and cancer-related financial strain as the impact on the 
individual (i.e. how the respondent had felt about their household’s financial situation since their 
cancer diagnosis). Response options for these questions were 7-level Likert-type scales ranging from 
“much more difficult”/”very concerned” to “much less difficult”/”much less concerned”. These were 
collapsed for analysis into three groups: more difficult/concerned, no change, and less 
difficult/concerned.  Those who fell into the categories more difficult or more concerned were 
considered to experience cancer-related financial stress or strain, respectively. For analysis, a third 
variable (cancer-related financial impact) was created based on the combination of responses to the 
financial stress and strain questions. This had three categories: both stress and strain, either stress 
or strain (but not both) and neither stress nor strain. 
 
Potential confounding variables 
Demographic, socio-economic and clinical variables are associated with HRQoL in colorectal 
cancer.28-30 The clinical variables available from the Registry were: site, stage at diagnosis, 
treatments received (cancer-directed surgery, chemotherapy, radiotherapy, and number of 
treatments) within a year of diagnosis and time since diagnosis.  Presence of a stoma was self-
reported on the questionnaire.  Demographic variables from the questionnaire were: age at 
questionnaire completion; marital status; whether the individual lived with others or alone; 
nationality; sex; and whether the individual had children. Socio-economic variables derived from the 
questionnaire were: highest level of education completed, employment status at the time of 
diagnosis, and the identity of the main earner in the household. 
 
Statistical Analysis 
Socio-demographic and clinical characteristics of responders and non-responders were compared 
using chi-square tests. Mean HRQoL scores were compared between cancer-related financial stress, 
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strain and impact groups using analysis of variance and the magnitude of the differences assessed 
for clinical significance; following Osoba et al.31 differences of 5–9.9, 10–19.9 and ≥20 points were 
considered ‘minimally’, ‘moderately’ and ‘largely’ clinically significant, respectively. Regression 
models were developed to test associations between cancer-related stress and strain and HRQoL. 
Since the key assumptions underlying linear regression were violated, HRQoL was collapsed into a 
binomial outcome allowing use of logistic regression. Since there is no pre-defined cut-off for low 
HRQoL, this was defined a priori as the 25% of individuals with the lowest HRQoL scores.  To build a 
multivariable model, relationships between each demographic, socio-economic and clinical variable 
and HRQoL were evaluated. Variables which were significant (p<0.05) were fitted simultaneously 
and those which remained significant at this level (and which were not collinear with other variables) 
were retained in the model. Cancer-related financial stress, cancer-related financial strain, and 
cancer-related financial impact were added (separately) to this model. The final models had 
adequate fit. In sensitivity analyses, the final models were re-run using multiple linear regression. All 
analyses were conducted in Stata 14.0. 
 
RESULTS 
Respondents’ characteristics and HRQoL 
In total, 496 survivors returned questionnaires; responses from three individuals were very 
incomplete so they were excluded, leaving 493 for analysis (response rate 39%).  Responders and 
non-responders did not differ significantly in terms of sex; cancer site; receipt of surgery, 
chemotherapy or radiotherapy; stage at diagnosis; or time since diagnosis. They did differ by age 
(p<0.01); non-responders were, on average, slightly older than responders.  
 
Demographic, socio-economic and clinical characteristics of responders are shown in Table 1.  Men 
accounted for 63% of respondents; almost 40% were aged under 65, 33% were 65-74 and 28% were 
75 and older; 38% were within a year of diagnosis, 48% were 1-2 years and 15% were ≥2 years from 
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diagnosis; 62% had colon cancer; 86% had had cancer-directed surgery; 28% had had chemotherapy; 
16% had had radiotherapy; and 22% currently had a stoma. 
 
474 respondents provided information on HRQoL. The mean score was 69.8 (sd 21.6); the median 
was 66.7 (inter-quartile range 50.0-83.3).  
 
Cancer-related financial stress, strain and impact 
464 respondents completed the cancer-related financial stress question. Of these, 41.0% had 
cancer-related financial stress (i.e. they reported that cancer had made it more difficult for their 
household to make ends meet); 56.7% reported no change; and 2.4% reported that cancer had 
made it less difficult to make ends meet (Figure 1). 
 
Information about cancer-related financial strain was provided by 467 respondents.  39.4% had 
cancer-related financial strain (i.e. they were more concerned about their household’s financial 
situation since their cancer diagnosis); 48.4% reported no change; and 12.2% reported that they 
were less concerned (Figure 1).   
 
Of the 461 respondents who answered both questions, 32.1% reported both financial stress and 
strain, 16.7% reported either financial stress or strain, and 51.2% reported neither financial stress 
nor strain. 
 
Demographic, socio-economic and clinical variables and low HRQoL 
Associations between individual demographic, socio-economic and clinical variables and low HRQoL 
are shown in Supplementary Table 1. Receipt of chemotherapy, presence of a stroma, having 
children and educational level remained in the multivariate model (Table 2). The odds of low HRQoL 
were 40% lower in those who had had chemotherapy (adjusted OR=0.59, 95%CI 0.36-0.98) 
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compared to those who had not, and were 80% higher in those who currently had a stoma (OR=1.80, 
95% CI 1.11-2.92) compared to those who did not. Compared to those with a secondary level 
education, those who had completed only primary education had almost two-fold raised odds of low 
HRQoL (OR=1.97, 95%CI 1.21-3.19). Having children was also associated with two-fold raised odds 
(OR=2.18, 95%CI 1.24-3.83).   
 
Mean HRQoL by cancer-related financial stress, strain and impact  
Mean HRQoL scores varied significantly by cancer-related financial stress, strain and impact 
(Supplemental Table 2; all p<0.001). The mean HRQoL among those who reported cancer-related 
financial stress was 12.9 points lower than among those who reported no change, a moderately 
clinically significant difference. The difference in mean HRQoL between those reporting financial 
strain versus no change (9.2 points) was minimally clinically significant. Those who reported both 
cancer-related financial stress and strain had a moderately clinically significantly higher mean HRQoL 
than those who reported neither stress nor strain (difference 13.6 points). 
 
Cancer-related financial stress, strain, and impact and low HRQoL 
38% of those who reported cancer-related financial stress had low HRQoL, compared to 19% who 
stated that cancer had had no impact on their household’s financial situation, and 10% who reported 
that their household’s financial situation was less difficult since diagnosis (chi-square p<0.001); 
unadjusted ORs are shown in Supplementary Table 1.  After adjusting for educational level, children, 
current stoma and chemotherapy, there was a significant association between cancer-related 
financial stress and low HRQoL (likelihood ratio test (LRT) p<0.001). The odds of low HRQoL were 
significantly higher in those with cancer-related financial stress compared to those reporting no 
change (OR=2.54, 95%CI 1.62-2.3.99)(Table 3).  
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Low HRQoL was present in 34% of those reporting cancer-related financial stress, compared to 23% 
of those who stated that their feeling about their household’s financial situation had not changed, 
and 14% of those who indicated that they were less concerned (chi-square p=0.003). ORs are shown 
in Supplementary Table 1. After adjustment, there was a significant association between cancer-
related financial strain and low HRQoL (LRT p=0.009). Compared to those reporting no change, the 
odds of low HRQoL were 1.73 times higher (95%CI 1.09-2.72) in those who experienced cancer-
related financial strain (Table 3). 
 
Compared to those with neither cancer-related financial stress nor strain, the multivariable ORs 
were 1.39 (95%CI 0.73-2.65) for those with either stress or strain and 2.59 (95%CI 1.59-4.99) for 
those with both (Table 3). 
 
Sensitivity analysis 
In the sensitivity analysis using linear regression, all three financial hardship variables were 
significantly associated with HRQoL after adjusting for socio-demographic and clinical variables; 
patterns of association were very similar to those from logistic regression (Supplementary Table 3). 
 
DISCUSSION 
Prevalence of cancer-related financial hardship 
In this study, four in every 10 colorectal cancer survivors reported experiencing either cancer-related 
financial stress or cancer-related financial strain, and one-third experienced both. It is difficult to 
compare levels, or prevalence, of cancer-related financial difficulties between studies because 
authors have used very different questions9 which probably measure somewhat different constructs.  
Despite this, it was noteworthy that prevalence of cancer-related financial impact in our study was 
similar to prevalence of cancer-related financial hardships in a US study of colon cancer survivors,15 
particularly given that cancer patients in Ireland are entitled to care within the public healthcare 
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system and, while most patients incur some cancer-related out-of-pocket costs, for the majority 
these are relatively modest.6 This suggests that cancer can have a significant financial impact on 
colorectal cancer patients in different healthcare systems (and even where there is public provision) 
and provides further evidence to suggest that financial protections in health are inadequate.32   
 
Compared to a study breast and prostate cancer survivors in Ireland, which used the same financial 
impact questions, the prevalence of cancer-related financial stress in the current study was lower 
(41% vs 48%) and the prevalence of financial strain was higher (39% vs 32%).27 In the breast and 
prostate cancer study, employment status at diagnosis was an important predictor of financial 
impact, with risk highest in the group who were working at diagnosis; this was most likely explained 
by income “shock” i.e. loss of income as a result of time away from work due to cancer. In the 
current study, the percentage reporting cancer-related financial stress was higher among colorectal 
cancer survivors working at diagnosis than other groups (employed/self-employed 58%; retired 29%, 
other 32%) but the proportion of colorectal cancer survivors in paid work at diagnosis was lower 
than among breast and prostate cancer survivors.33,34 This could account for the lower prevalence of 
cancer-related financial stress in colorectal survivors.  
 
The higher prevalence of financial strain is more difficult to explain. Some colorectal cancer survivors 
experience ongoing cancer-related costs (e.g. stoma bags, clothes, dietary supplements) and it could 
be that these recurring costs (albeit modest) serve to remind survivors of financial outlays and 
stimulate financial concerns. Notably, 50% of those with a stoma at the time of the survey reported 
cancer-related financial strain compared to 36% of those without a stoma.  
 
In terms of other drivers of cancer-related financial hardship in this population, in post hoc analyses 
we found no association with out-of-pocket costs.  However, as we have noted elsewhere,6 the 
magnitude of out-of-pocket costs is partly a function of ability to pay (i.e. those with higher costs are 
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often those most able to meet these costs). Both private health insurance and access to medical 
cards appear to provide some protection against cancer-related financial hardship. The prevalence 
of financial stress was higher in those without private health insurance (46% vs 37%) and the 
prevalence of both stress and strain was higher in those without a medical card at diagnosis (stress: 
47% vs 36%; strain 47% vs 32%), although the high frequency of stress and strain in those without 
these financial protections indicated that other factors are involved. Beyond this study, although 
recognition is growing that cancer can cause financial hardship/difficulties/impact,10,35-36 relatively 
little is known about the prevalence or what predisposes cancer survivors to them, especially for 
specific cancers and outside the US. The current study extends the evidence-base, but further 
research in these areas is urgently required.  In particular, it would be useful to better understand 
drivers of - and buffers against – cancer-related financial hardship in settings like Ireland where 
publicly-funded healthcare is available. 
 
Cancer-related financial stress and strain and HRQoL 
Cancer-related financial stress and strain, and the combination of these, were associated with low 
HRQoL after adjusting for socio-demographic and clinical factors. Moreover, the difference in mean 
HRQoL scores between those who reported cancer-related financial stress or strain and those who 
did not attained clinical significance. 
 
Studies in other cancers have reported associations between financial burden and poorer 
psychological wellbeing.18,20  From qualitative research, we have previously postulated inter-play 
between the financial and emotional impacts of colorectal cancer such that financial distress may 
exacerbate emotional distress.37 This is compatible with research in the population which indicates 
that poverty imposes a cognitive load and consumes mental resources.38 Others have reported 
associations between poorer psychological wellbeing and lower HRQoL in colorectal cancer.39 This 
suggests that our findings could be indirectly due to the financial impact adversely affecting 
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emotional wellbeing.  A recent study observed that colorectal cancer patients with limited financial 
reserves (i.e. savings) 4-months post-diagnosis had a significantly higher symptom burden40 and, 
since symptoms are strong predictors of HRQoL, this provides another possible explanation.  Future 
studies should seek to test whether cancer-related financial distress affects HRQoL by influencing 
psychological wellbeing, symptom burden, or though some other route.  There is also a need to 
understand the (potentially different) pathways underlying development of objective and subjective 
cancer-related financial distress; it is possible that distinct interventions or supports may be needed 
to alleviate these different dimensions of the financial impact of cancer. 
 
Practice Implications 
The relationship between financial impact of cancer and low HRQoL means healthcare professionals 
should be alert to the possibility of financial distress (objective or subjective) among survivors, and 
seek to identify this at an early stage. From a policy- and decision-maker perspective, the 
development of strategies or supports to alleviate the (objective or subjective) financial impact of 
colorectal cancer could lead to improved HRQoL. 
 
Strengths & Limitations 
Although study participants were identified from a population-based sampling frame, the response 
rate was only 39%. It was reassuring, therefore, that the socio-demographic and clinical 
characteristics of respondents and non-respondents differed only in age and age was not a 
significant predictor of HRQoL.  Some people who returned the questionnaire did not complete the 
HRQoL questions or the questions on cancer-related financial stress and strain; although numbers 
were small, those who did not complete these sections tended to be older on average than those 
who did.  We cannot exclude the possibility that those who completed all of the questions, those 
who completed some, and non-respondents differed in cancer-related financial stress or strain or 
HRQoL. The questions on cancer-related financial stress and strain had been used in previous studies 
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and showed good convergent validity with other markers of the financial burden of cancer in 
survivors in Ireland.20 They were designed to investigate objective and subjective aspects of the 
financial impact of cancer16 and – as far as we are aware - this is the first study of these two 
dimensions of financial burden in colorectal cancer survivors. However, we acknowledge that both 
questions are somewhat subjective in nature in that they ask about respondents’ own views of the 
financial impact of cancer on their household and self. In addition, we lacked information on 
comorbid conditions, and it is possible that (although the questions asked about the impact of the 
cancer) for some survivors the financial hardship may result from presence of other conditions. 
Moreover, we note that the data was collected some time ago (notably, before the full impact of the 
economic crisis in Ireland). It is therefore unclear whether current frequencies of financial stress and 
strain would be the same as reported here. Finally, in common with other studies on this topic, it 
cannot be assumed that the prevalence of financial hardship (irrespective of how measured) in 
Ireland is representative of experiences in other countries. 
 
Because assumptions underlying linear regression were violated we used logistic regression for our 
primary analysis. A lack of a generally-recognised threshold for low HRQoL (as measured using the 
global health score from the EORTC QLQ-C30) led us to define this a priori as the lowest quantile, but 
whether this corresponds to clinical importance is unknown. Thresholds for clinical importance have 
recently been published for several other EORTC QLQ-C30 subscales;41 a similar thresholds for the 
global health score would be of considerable value.  
 
Conclusions 
In this first study to distinguish between objective and subjective measures of cancer-related 
financial impact in colorectal cancer, four in every 10 survivors reported objective cancer-related 
financial stress, four in 10 reported subjective cancer-related financial strain, and one-third reported 
both. Survivors experiencing cancer-related financial stress and/or strain had significantly increased 
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odds of low health-related quality-of-life, and the differences in HRQoL between those with and 
without financial stress or strain were clinically significant. Further research is needed to better 
understand the routes by which financial distress affects HRQoL among cancer survivors. Meantime, 
greater recognition of the (objective and subjective) financial impact of cancer on survivors and their 
families, and the development of strategies to alleviate this, could yield HRQoL benefits. 
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Figure Legends 
 
Figure 1: Distribution of cancer-related financial stress and strain among colorectal cancer 
survivors 
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Table 1. Characteristics of colorectal cancer survivors included in analysis. Numbers and
percentages.
Number %
Total 493 100.0
Demographic variables
Sex
Male 310 62.9
Female 183 37.1
Age at time of questionnaire completion
<65 194 39.4
65-74 163 33.1
75+ 136 27.6
Marital status at diagnosis
Married/cohabiting 373 75.8
Other 119 24.2
Not reported 1
Living alone at time of diagnosis
No 409 83.5
Yes 81 16.5
Not reported 3
Children
Yes 420 86.2
No 67 13.8
Not reported 6
Nationality
Irish 467 94.9
Other 25 5.1
Not reported 1
Socio-economic variables
Highest level of education completed
Primary 146 29.9
Secondary 236 48.3
Tertiary 107 21.9
Not reported 4
Employment status at diagnosis
Employed/self-employed 188 38.9
Retired 203 42.0
Other 92 19.1
Not reported 10  
Table
Main earner in household
Survivor 300 62.6
Spouse/other 118 24.6
Shared between survivor/spouse 61 12.7
Not reported 14
Private health insurance at diagnosis
No 239 48.5
Yes 254 51.5
Medical card at diagnosis 1
Yes 241 48.9
No 252 51.1
Clinical variables
Time since diagnosis
<1 year 185 37.5
1-2 years 234 47.5
>2 years 74 15.0
Site
colon 305 61.9
rectum 188 38.1
Stage at diagnosis
Stage 1 91 18.5
Stage 2 141 28.6
Stage 3 175 35.5
Stage 4 36 7.3
Not known/ not staged 50 10.1
Cancer-directed surgery
Yes 425 86.2
No 68 13.8
Chemotherapy
Yes 138 28.0
No 355 72.0
Radiotherapy
Yes 80 16.2
No 413 83.8
Number of treatments received
None 44 8.9
1 286 58
2 132 26.8
3 31 6.3  
Currently has a stoma
Yes 105 21.3
No 388 78.7
1 eligibility based on financial means and age; provides access to healthcare in public system, GPs, and
prescription medications free at the point of delivery
 
 
 
  
Table 2. Associations between significant demographic,  socio-economic
and clinical variables and low HRQoL: numbers and % with low HRQoL, adjusted odds 
ratios (AdjOR)1 with 95% confidence intervals (CI), and p values from likelihood ratio tests
Number % AdjOR 95% CI p
Children
Yes 98 24.2 1.00 - 0.008
No 26 40.0 2.18 1.24-3.83
Highest level of education completed
Primary 47 34.0 1.97 1.21-3.19 0.021
Secondary 51 22.1 1.00 -
Tertiary 26 24.8 1.17 0.67-2.04
Chemotherapy
No 98 28.6 1.00 - 0.037
Yes 26 19.9 0.59 0.36-0.98
Current stoma
No 87 23.4 1.00 - 0.019
Yes 37 36.3 1.80 1.11-2.92
1 mutually adjusted for the variables shown in the table
 
  
Table 3. Associations between cancer-related financial impact and low HRQoL, adjusted for demographic, socio-economic
and clinical variables: numbers and % with low HRQoL, adjusted odds ratios (AdjOR)1 with 95%  confidence intervals
(CI), and p values from likelihood ratio tests
Number % AdjOR 95% CI p
Cancer-related financial stress 2
financial stress better since diagnosis 1 10.0 0.45 0.06-3.71 <0.001
no change 48 18.8 1.00 -
financial stress worse since diagnosis 71 37.8 2.54 1.62-3.99
Cancer-related financial strain 3
financial strain better since diagnosis 8 14.0 0.61 0.26-1.39 0.009
no change 50 22.8 1.00 -
financial strain worse since diagnosis 62 34.3 1.73 1.09-2.72
Cancer-related financial impact
neither stress nor strain worse 44 19.2 1.00 - <0.0014
either stress or strain worse 18 23.7 1.39 0.73-2.65
both stress and strain worse 57 39.0 2.59 1.59-4.22
1 adjusted for having children, highest level of education completed, receipt of chemotherapy and current stoma
2 impact of cancer diagnosis on household's ability to make ends meet
3 feelings about household financial situation since cancer diagnosis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Supplementary Table 1: Univariate associations between variables and low HRQoL.  Numbers and percentages with
low HRQoL, odds ratios (OR), 95% confidence intervals (OR) and p values from likelihood ratio tests
Number % OR 95%CI p
Demographic variables
Sex
Male 77 25.7 1 - 0.749
Female 47 27.0 1.07 0.70-1.64
Age at time of questionnaire completion
<65 43 22.6 1 - 0.324
65-74 44 27.5 1.30 0.80 - 2.11
75+ 37 29.8 1.45 0.87 - 2.43
Marital status at diagnosis
Married/cohabiting 90 25.1 1 - 0.414
Other 34 29.1 1.21 0.76-1.93
Living alone at diagnosis
No 100 25.5 1 - 0.502
Yes 23 29.1 1.20 0.70 - 2.06
Children
Yes 98 24.2 1 - 0.010
No 26 40.0 2.09 1.21-3.60
Nationality
Irish 116 25.8 1 - 0.423
Other 8 33.3 1.44 0.60-3.45
Socio-economic variables
Highest level of education completed
Primary 47 34.0 1.82 1.14-2.92 0.041
Secondary 51 22.1 1 -
Tertiary 26 24.8 1.16 0.68-2.00
Employment status at diagnosis
Employed/self-employed 43 23.4 1 - 0.447
Retired 57 29.1 1.34 0.85-2.13
Other 22 25.9 1.15 0.63-2.07
Main earner in household
Survivor 85 29.1 1 - 0.179
Spouse/other 24 21.1 0.65 0.39 -1.09
Shared between survivor/spouse 13 22.0 0.69 0.35-1.34
Private health insurance at diagosis
No 62 25.9 1 -
Yes 62 24.1 0.92 0.61-1.38 0.695
Medical card at diagnosis
No 55 22.8 1 -
Yes 69 27.4 1.27 0.83-1.92 0.243
 
Clinical variables
Time since diagnosis
<1 year 44 24.7 0.87 0.56-1.37 0.831
1-2 years 61 27.4 1 -
>2 years 19 26.0 0.93 0.51-1.70
Site
Colon 67 23.0 1 - 0.059
Rectum 57 31.0 1.49 0.99 - 2.26
Stage at diagnosis
Stage 1 22 25.0 0.85 0.47-1.53 0.718
Stage 2 31 23.1 0.77 0.45-1.30
Stage 3 47 28.1 1 -
Stage 4 8 22.9 0.76 0.32-1.78
Not known/ not staged 16 32.0 1.20 0.61-2.38
Cancer-directed surgery
Yes 14 21.5 1 -
No 110 26.9 1.34 0.71-2.52 0.353
Chemotherapy
No 98 28.6 1 - 0.049
Yes 26 19.9 0.62 0.38 - 1.01
Radiotherapy
No 106 26.7 1 - 0.540
Yes 18 23.4 0.84 0.47 - 1.48
Number of treatments received
None 9 21.4 0.63 0.29-1.37 0.068
1 84 30.3 1 -
2 23 18.4 0.52 0.31-0.87
3 8 26.7 0.84 0.36-1.95
Currently has a stoma
Yes 87 23.4 1 - 0.011
No 37 36.3 1.86 1.17-2.98
Financial impact variables
Cancer-related financial stress 1
financial stress better since diagnosis 1 10.0 0.48 0.06-3.87 <0.001
no change 48 18.8 1 -
financial stress worse since diagnosis 71 37.8 2.61 1.70-4.03
Cancer-related financial strain 2
financial strain better since diagnosis 8 14.0 0.55 0.25-1.24 0.003
no change 50 22.8 1 -
financial strain worse since diagnosis 62 34.3 1.76 1.13-2.73
Cancer-related financial impact
neither stress nor strain worse 44 19.2 1 - <0.001
either stress or strain worse 18 23.7 1.30 0.70-2.43
both stress and strain worse 57 39.0 2.69 1.69-4.30
1 impact of cancer diagnosis on household's ability to make ends meet
2 feelings about household financial situation since cancer diagnosis
Supplementary Table 2: HRQoL scores by cancer-related financial impact: 
means, standard deviations (sd) and p values from analysis of variance F test
Mean sd p
Cancer-related financial stress 1
financial stress better since diagnosis 81.7 19.6 <0.001
no change 74.8 19.8
financial stress worse since diagnosis 61.9 22.0
Cancer-related financial strain 2
financial strain better since diagnosis 74.9 22.9 <0.001
no change 73.1 20.6
financial strain worse since diagnosis 63.9 21.2
Cancer-related financial impact
neither stress nor strain worse 75.2 20.2 <0.001
either stress or strain worse 68.1 21.0
both stress and strain worse 61.6 21.6
1 impact of cancer diagnosis on household's ability to make ends meet
2 feelings about household financial situation since cancer diagnosis  
 
 
Supplementary Table 3. Sensitivity analysis - linear regression: associations between cancer-related 
financial impact and HRQoL, adjusted for demographic, socio-economic and clinical variables: 
coefficients, standard errors,  95%  confidence intervals (CI) and p values 
Coefficient 1 95% CI p
Cancer-related financial stress 2
financial stress better since diagnosis -12.04 -15.98 to -8.09 <0.001
no change ref -
financial stress worse since diagnosis 7.02 -5.99 to 20.03
Cancer-related financial strain 3
financial strain better since diagnosis -8.61 -12.76 to -4.47 0.009
no change ref -
financial strain worse since diagnosis 0.85 -5.32 to 7.01
Cancer-related financial impact
neither stress nor strain worse ref - <0.001
either stress or strain worse -7.46 -12.86 to -2.06
both stress and strain worse -12.66 -17.01 to -8.32
1 adjusted for having children, highest level of education completed, receipt of chemotherapy and current stoma
2 impact of cancer diagnosis on household's ability to make ends meet
3 feelings about household financial situation since cancer diagnosis
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